Connect with us

Life Sciences

Accelerating Organoid-Based Scientific Discovery

In this GEN webinar, two experts in 3D cell culture and organoid biology, Dr. Elizabeth Abraham from Corning Life Sciences and Dr. Lauretta Lacko from…

Published

on

This article was originally published by GEN Genetic Engineering and Biotechnology News

Broadcast Date: April 28, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

There is intense interest in research applications of organoids—mini-organs grown in a dish that are made up of different cell types that self-organize into tissue assemblies. By accurately mimicking human tissue biology, organoids hold great promise to revolutionize scientific discovery and healthcare with multimodal potential for new drug development, precision medicine, and regenerative medicine. Human organoids can be derived from either human pluripotent stem cells (hPSCs) or primary biopsy or autopsy tissues. However, there are significant challenges in quality control and reproducibility.

In this webinar, two experts in 3D cell culture and organoid biology will share their expertise on this exciting field. Dr. Elizabeth Abraham (Corning Life Sciences) will discuss the latest developments in 3D cell culture, including key applications, new tools and technologies, and bridging the pre-clinical gap. The main presentation will be given by Dr. Lauretta Lacko (Weill Cornell Medicine), who will discuss the myriad medical applications of organoids. She will draw on her insights running the Human Therapeutic Organoid Core (HTOC) facility, providing quality organoids to the scientific community, in particular the value of sourcing high-quality reagents and optimizing protocols.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.

Elizabeth Abraham, PhD
Elizabeth Abraham, PhD
Market Manager,
3D Cell Culture
Corning Life Sciences
Lauretta Lacko
Lauretta A. Lacko, PhD
Assistant Professor of Cell Biology Research
Weill Cornell Medicine

corning logo

The post Accelerating Organoid-Based Scientific Discovery appeared first on GEN – Genetic Engineering and Biotechnology News.

stem cells

life sciences

Markets

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending